Kestra Advisory Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $109K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $286K | Sell |
|
|||||
|
2024
Q4 | $426K | Sell |
|
|||||
|
2024
Q3 | $631K | Sell |
|
|||||
|
2024
Q2 | $665K | Buy |
|
|||||
|
2024
Q1 | $869K | Buy |
|
|||||
|
2023
Q4 | $705K | Buy |
|
|||||
|
2023
Q3 | $525K | Buy |
|
|||||
|
2023
Q2 | $553K | Sell |
|
|||||
|
2023
Q1 | $569K | Sell |
|
|||||
|
2022
Q4 | $1.91M | Buy |
|
|||||
|
2022
Q3 | $1.57M | Sell |
|
|||||
|
2022
Q2 | $1.79M | Buy |
|
|||||
|
2022
Q1 | $2.04M | Buy |
|
|||||
|
2021
Q4 | $2.29M | Buy |
|
|||||
|
2021
Q3 | $1.8M | Buy |
|
|||||
|
2021
Q2 | $1.56M | Sell |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | $249K | Buy |
|